Ara
Toplam kayıt 32, listelenen: 1-10
Does heart failure with mid-range ejection fraction resemble heart failure with preserved ejection fraction?
(Springer, 2020)
[No abstract available]
Hydroxychloroquine/azithromycin treatment, QT interval and ventricular arrhythmias in hospitalised patients with COVID-19
(Wiley, 2021)
Hydroxychloroquine (HCQ) and azithromycin (AZM) are widely used in off‐label treatment of novel coronavirus disease (COVID‐19). However, cardiac safety of these drugs is still controversial in COVID‐19. Therefore, we aimed ...
Permanent atrial fibrillation portends poor outcomes in hospitalized patients with COVID-19: A retrospective observational study
(Elsevier, 2021)
Background: Data specifically addressed to whether atrial fibrillation (AF) would contribute to increasing the risk for severe forms of novel coronavirus disease (COVID-19) or worse prognosis remain unclear. Hence, we ...
Patients with HFpEF and HFmrEF have different clinical characteristics in Turkey: A multicenter observational study
(Elsevier Science Bv, 2019)
Background: To determine and compare the demographic characteristics, clinical profile and management of patients with heart failure with mid-range ejection fraction (HFmrEF) and heart failure with preserved ejection ...
Non-invasive ventilation in community acquired pneumonia
(W B Saunders Co-Elsevier Inc, 2019)
Emergency department crowding and sepsis
(W B Saunders Co-Elsevier Inc, 2018)
Right Heart Function in Community-Acquired Pneumonia
(Elsevier Science Inc, 2019)
Reply to the letter: “Kounis syndrome: towards a new classification”
(Elsevier, 2021)
Letter to the Editor
Predictors of mortality in sepsis
(W B Saunders Co-Elsevier Inc, 2016)
The risk stratification in community-acquired pneumonia
(W B Saunders Co-Elsevier Inc, 2019)